Cargando…
Nanostructured Lipid Carriers Engineered as Topical Delivery of Etodolac: Optimization and Cytotoxicity Studies
Etodolac (ETD), a nonsteroidal anti-inflammatory drug, exhibits antinflammatory, analgesic, and antipyretic activity. The main type of ETD administration is oral route, which is associated with significant systemic side effects. Nanostructured lipid carriers (NLC), a modern lipid formulation, are no...
Autores principales: | Czajkowska-Kośnik, Anna, Szymańska, Emilia, Czarnomysy, Robert, Jacyna, Julia, Markuszewski, Michał, Basa, Anna, Winnicka, Katarzyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866147/ https://www.ncbi.nlm.nih.gov/pubmed/33514018 http://dx.doi.org/10.3390/ma14030596 |
Ejemplares similares
-
Nanostructured Lipid Carriers (NLC)-Based Gel Formulations as Etodolac Delivery: From Gel Preparation to Permeation Study
por: Czajkowska-Kośnik, Anna, et al.
Publicado: (2022) -
Development and Evaluation of Liquid and Solid Self-Emulsifying Drug Delivery Systems for Atorvastatin
por: Czajkowska-Kośnik, Anna, et al.
Publicado: (2015) -
Ethylcellulose in Organic Solution or Aqueous Dispersion Form in Designing Taste-Masked Microparticles by the Spray Drying Technique with a Model Bitter Drug: Rupatadine Fumarate
por: Wasilewska, Katarzyna, et al.
Publicado: (2019) -
The Correlation between Physical Crosslinking and Water-Soluble Drug Release from Chitosan-Based Microparticles
por: Szymańska, Emilia, et al.
Publicado: (2020) -
Nanoemulsions as a Promising Carrier for Topical Delivery of Etodolac: Formulation Development and Characterization
por: Özdemir, Samet, et al.
Publicado: (2023)